Long-term naltrexone treatment reduces the exaggerated insulin secretion in patients with polycystic ovary disease
(Q72845082)
scientific article published on 01 August 1993
scientific article published on 01 August 1993
Language:
Current Data About
Long-term naltrexone treatment reduces the exaggerated insulin secretion in patients with polycystic ovary disease